Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study

INTRODUCTION: Primary brain tumours, specifically gliomas, are a rare disease group. The disease and treatment negatively impacts on patients and those close to them. The high rates of physical and cognitive morbidity differ from other cancers causing reduced health-related quality of life. Glioma t...

Descripción completa

Detalles Bibliográficos
Autores principales: Retzer, Ameeta, Sivell, Stephanie, Scott, Hannah, Nelson, Annmarie, Bulbeck, Helen, Seddon, Kathy, Grant, Robin, Adams, Richard, Watts, Colin, Aiyegbusi, Olalekan Lee, Kearns, Pamela, Cruz Rivera, Samantha, Dirven, Linda, Baddeley, Elin, Calvert, Melanie, Byrne, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528585/
https://www.ncbi.nlm.nih.gov/pubmed/36180121
http://dx.doi.org/10.1136/bmjopen-2021-057712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528585/
https://www.ncbi.nlm.nih.gov/pubmed/36180121
http://dx.doi.org/10.1136/bmjopen-2021-057712

Ejemplares similares